AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 165 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $982 | -10.0% | 40,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,091 | +146.3% | 40,000 | +100.0% | 0.00% | +100.0% |
| Q1 2023 | $443 | -18.3% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $542 | -99.9% | 20,000 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $568,000 | +29.4% | 20,000 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $439,000 | +367.0% | 20,000 | +614.3% | 0.00% | – |
| Q4 2021 | $94,000 | -94.4% | 2,800 | -92.4% | 0.00% | -100.0% |
| Q3 2021 | $1,688,000 | -13.2% | 36,700 | 0.0% | 0.01% | -16.7% |
| Q2 2021 | $1,944,000 | +8.0% | 36,700 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $1,800,000 | +20.6% | 36,700 | +8.3% | 0.01% | 0.0% |
| Q4 2020 | $1,492,000 | +23.7% | 33,900 | -4.8% | 0.01% | +20.0% |
| Q3 2020 | $1,206,000 | +743.4% | 35,600 | +1093.8% | 0.01% | +400.0% |
| Q4 2019 | $143,000 | – | 2,982 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 354,650 | $18,314,000 | 7.19% |
| Casdin Capital, LLC | 2,165,000 | $111,801,000 | 3.33% |
| Rock Springs Capital Management LP | 2,543,600 | $131,352,000 | 2.87% |
| HealthCor Management, L.P. | 1,532,960 | $79,162,000 | 2.80% |
| Bellevue Group AG | 4,537,092 | $234,295,000 | 2.48% |
| Woodline Partners LP | 824,097 | $42,556,000 | 0.94% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,081,347 | $55,841,000 | 0.83% |
| Integral Health Asset Management, LLC | 43,000 | $2,221,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,119,566 | $57,814,000 | 0.43% |
| Virtus ETF Advisers LLC | 18,328 | $946,000 | 0.40% |